← Open Payments lookup

HEMANGINI PATEL: Open Payments

NPI 1558761924 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,344 in 54 payments from 11 companies in 2025. Trend: 2023 $429 · 2024 $1,606 · 2025 $1,344

Food & beverage: $1,344
CompanyPaymentsAmount
Incyte Corporation11$267
UCB, Inc.8$259
ABBVIE INC.10$225
Lilly USA, LLC9$194
Regeneron Healthcare Solutions, Inc.3$85
Janssen Biotech, Inc.3$78
Novartis Pharmaceuticals Corporation3$78
Arcutis Biotherapeutics, Inc.3$66
Galderma Laboratories, L.P.2$45
LEO Pharma Inc.1$25

Products named: OPZELURA, Bimzelx, SKYRIZI, TALTZ, TREMFYA, Zoryve, DUPIXENT, Rhapsido.

Industry payments across CA — which companies pay providers there.